An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer’s disease. The corresponding study was published in Alzheimer’s & Dementia. "Alzheimer's disease begins ...

An inside look at an opaque process by Paul Gompers, Will Gornall, Steven N. Kaplan and Ilya A. Strebulaev Over the past 30 years, venture capital has been a vital source of financing for high-growth ...